Octahydroquinoli zines for antidiabetic treatment

Details for Australian Patent Application No. 2008338287 (hide)

Owner 55pharma Drug Discovery & Development AG

Inventors Furnsinn, Clemens; Bauer, Leonhardt; Adorjan, Immanuel; Frobel, Klaus

Agent Fisher Adams Kelly

Pub. Number AU-B-2008338287

PCT Pub. Number WO2009/076693

Priority A 1315/2008 25.08.08 AT; 07450235.2 19.12.07 EP

Filing date 17 December 2008

Wipo publication date 25 June 2009

Acceptance publication date 7 June 2012

International Classifications

C07D 455/02 (2006.01) Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine

A61K 31/4375 (2006.01)

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

C07D 405/06 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

3 June 2010 PCT application entered the National Phase

  PCT publication WO2009/076693 Priority application(s): WO2009/076693

7 June 2012 Application Accepted

  Published as AU-B-2008338287

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008338288-Treatment of inflammatory illnesses with ACE2

2008338281-Coupling for interconnecting at least two pipes